{"text_format":"3","workbook":"xlsx","n_sheets":3,"sheets":["Config","Home Page","PCHD 5 Year Plan"],"not_rendered":{"macros":1,"defined_names":24,"comments":2},"read":"whole","date_system":"1900"}

{"sheet":"Config","index":0,"n_rows":69,"n_cols":20,"rows_kept":69,"hidden":true}
["Template Configuration Sheet"]
["This configuration sheet is used to store settings for the rest of the workbook and maximize flexibility."]
["The following formatting is used on this worksheet:"]
["[Name of Range]","Input Cell(s)"]
["[Name of Range]","value from other named location"]
[]
["Configuration Values",null,null,"Lookup Values"]
[{"$nulls":13},"Use this section to configure text displayed on the workbook tabs-->>"]
["PerformanceYear",1,null,"lkpOrgNames",null,"lkpYN",null,"lkpImplementation",null,"lkpImportance",{"$nulls":3},"lkpStrategy_ID","lkpStrategy_Text","lkpStrategyAreas_Text","lkpStrategyAreas_ID",null,"lkpSubStrategy_ID","lkpSubStrategy_Text"]
["TemplateType","5 Year Plan",null,"[Choose your Project Area…]",null,"Y",null,"We are very strong in this strategy",null,"Extremely Important ",{"$nulls":3},1,"Conduct Chlamydia (CT) surveillance","Conduct Surveillance ",1,null,"1A","Collect, manage, analyze, interpret and disseminate data on identified cases of chlamydia, ensuring timely capture of core epidemiological variables available on laboratory reports: age, sex, county, diagnosing facility type, specimen collection date, and anatomic site(s) of infection"]
["TemplateVersion",1,null,"Alabama",null,"N",null,"We are somewhat strong in this strategy",null,"Very Important",{"$nulls":3},2,"Conduct Gonorrhea (GC) surveillance","Conduct Surveillance ",1,null,"2A","Collect, manage, analyze, interpret and disseminate data on identified cases of gonorrhea, ensuring timely capture of core epidemiological variables available on laboratory reports: age, sex, county, diagnosing facility type, specimen collection date, and anatomic site(s) of infection"]
[{"$nulls":3},"Alaska",{"$nulls":3},"We are somewhat weak in this strategy",null,"Moderately Important",{"$nulls":3},3,"Conduct syphilis surveillance","Conduct Surveillance ",1,null,"2B","To better understand GC epidemiology, conduct provider follow-up and, if needed, brief patient interviews of a random sample of GC cases from a well-defined high morbidity area or the project area as a whole. Ensure timely and quality capture of core epidemiological variables including, but not limited to: age, sex, county, diagnosing facility type, specimen collection date, anatomic site(s) of infection, race/ethnicity, gender identity/sexual orientation, sex of sex partner(s), clinical signs/symptoms, pregnancy status, HIV status, partner treatment (i.e., EPT provision), gonorrhea-related sequelae (i.e., presence of pelvic inflammatory disease (PID), disseminated gonococcal infection (DGI), etc.), substance use, date of diagnosis, treatment received (including names and doses of treatment), date of treatment, co-infection with other STDs, and history of GC infection"]
["Title1","Strengthening STD Prevention and Control for Health Departments (STD PCHD)",null,"Arizona",{"$nulls":3},"We are very weak in this strategy",null,"Slightly Important",{"$nulls":3},4,"Conduct congenital syphilis (CS) surveillance","Conduct Surveillance ",1,null,"3A","Collect, manage, analyze, interpret and disseminate data on identified cases of syphilis, ensuring timely capture of core epidemiological variables available on laboratory reports: age, sex, county, diagnosing facility type, and specimen collection date"]
["Title2","5 Year Plan",null,"Arkansas",{"$nulls":3},"Can’t Judge - We Don’t Do Much around this Strategy",null,"Not Very Important",{"$nulls":3},5,"Conduct surveillance of adverse outcomes of STDs","Conduct Surveillance ",1,null,"3B","To better understand primary and secondary (P&S) syphilis epidemiology, conduct provider follow-up and, if needed, brief patient interviews of all cases of P&S syphilis. Ensure timely and quality capture of core epidemiological variables including, but not limited to: age, sex, county, diagnosing facility type, specimen collection date, race/ethnicity, gender identity/sexual orientation, sex of sex partner(s), pregnancy status, clinical signs/symptoms, HIV status, substance use, treatment received, date of treatment, and history of syphilis"]
["Title3","PCHD Years 1 - 5",null,"Baltimore",{"$nulls":9},6,"Respond to STD-related outbreaks","Conduct Disease Investigation and Intervention",2,null,"4A","To better understand CS epidemiology, conduct provider and mother follow-up and review medical records of all reported CS cases. Based on information collected, manage, analyze, and disseminate data on reported cases of CS, ensuring timely and quality capture of epidemiological core maternal, fetal, and neonatal variables including, but not limited to: mother's age, race/ethnicity, county, stage of syphilis diagnosed during pregnancy, date(s) of 1st prenatal visit, syphilis testing (and corresponding titers), treatment(s) and delivery; HIV status of mother, substance use, clinical settings of diagnosis and care; and fetal and neonatal information such as ultrasound findings, physical and laboratory findings, and HIV status of infant at birth"]
["AwardeeName",{"$f":"'Home Page'!C9","v":"[Choose your Project Area…]"},null,"California",{"$nulls":9},7,"Conduct health department disease investigation for pregnant women and other reproductive-age women with syphilis","Conduct Disease Investigation and Intervention",2,null,"4B","For applicants with 10 or more cases of congenital syphilis in the previous calendar year: Improve methods to match vital statistics birth and mortality data with syphilis surveillance data to review syphilis testing practices among women who delivered a stillborn baby, identify missed cases of syphilis-related stillbirth, and strengthen CS case report data"]
["PeriodOfPerformance","01/01/2019 - 12/31/2023",null,"Chicago",{"$nulls":9},8,"Promote Expedited Partner Therapy (EPT) (where permissible) to partners of chlamydia and/or gonorrhea cases","Conduct Disease Investigation and Intervention",2,null,"4C","For applicants with 10 or more cases of congenital syphilis in the previous calendar year: Strengthen CS morbidity and mortality case review boards at the local and/or state level to help identify causes of CS and develop interventions to address causes"]
["configObjectiveRowCount",10,null,"Colorado",{"$nulls":9},9,"Conduct health department syphilis disease investigation and intervention for men with syphilis","Conduct Disease Investigation and Intervention",2,null,"5A","Conduct active surveillance of adverse outcomes of adult syphilis including neurosyphilis and otic and ocular syphilis through sentinel approaches, collecting variables including, but not limited to: neurological manifestations, ocular manifestations, otic manifestations, and late clinical manifestations. These are in addition to the stage of syphilis and the core epidemiologic variables listed for P&S syphilis above"]
[{"$nulls":3},"Connecticut",{"$nulls":9},10,"Promote quality STD specialty care services","Promote CDC-Recommended Screening, Diagnosis, and Treatment",3,null,"6A","Review STD surveillance data by the core epidemiologic variables at regular intervals to identify outbreaks and other significant changes in STD epidemiology"]
[{"$nulls":3},"Delaware",{"$nulls":9},11,"Promote CDC-recommended treatment for gonorrhea and syphilis","Promote CDC-Recommended Screening, Diagnosis, and Treatment",3,null,"6B","Develop and maintain an outbreak capacity plan to respond to significant changes in STD epidemiology. Ensure that staff are trained and ready to implement the outbreak capacity plan"]
[{"$nulls":3},"District of Columbia",{"$nulls":9},12,"Promote CDC-recommended screening for, and treatment of, STDs among priority populations","Promote CDC-Recommended Screening, Diagnosis, and Treatment",3,null,"7A","Prioritize for investigation all reported cases among females of reproductive age and reactive serology, including provider follow-up to confirm stage, treatment and pregnancy status"]
[{"$nulls":3},"Florida",{"$nulls":9},13,"Promote STD prevention to the public","Promote STD Prevention and Policy",4,null,"7B","Regardless of pregnancy status, conduct follow-up on new syphilis cases among women of reproductive age, to obtain more information, if needed, on treatment and other information needed to ensure linkage to related STD, MCH, and HIV prevention and other services. For those who are pregnant, investigation should also include follow-up with the pregnant female, prenatal care providers, birthing centers, and neonatal care providers as needed to ensure adequate maternal follow up and stillbirth and neonatal evaluations per clinical guidelines"]
[{"$nulls":3},"Georgia",{"$nulls":9},14,"Promote STD prevention and reporting to provider community","Promote STD Prevention and Policy",4,null,"7C","Provide timely partner services to all pregnant women who are diagnosed with syphilis and all other women of reproductive age who are diagnosed with early syphilis"]
[{"$nulls":3},"Hawaii",{"$nulls":9},15,"Monitor STD-related policies and policy development","Promote STD Prevention and Policy",4,null,"8A","Assess EPT practices to identify and prioritize providers and organizations or areas to target for promotion and improvement.  Provide technical assistance and education to promote EPT to providers and organizations who frequently report cases of chlamydia and/or gonorrhea including cases of repeat infections"]
[{"$nulls":3},"Idaho",{"$nulls":9},16,"Conduct epidemiologic analysis, translation and dissemination","Analyze and Use Data for Program Improvement",5,null,"9A","Conduct follow-up on primary and secondary syphilis cases among men, to obtain more information, if needed, on treatment, sex of sex partners, HIV serostatus, HIV care status, PrEP use, and other information to ensure linkage to appropriate STD and HIV related prevention services"]
[{"$nulls":3},"Illinois",{"$nulls":9},17,"Conduct data-driven planning, analysis, monitoring and evaluation for program improvement","Analyze and Use Data for Program Improvement",5,null,"9B","Provide timely and comprehensive partner services to men with primary and secondary syphilis who report pregnant or other female partners of reproductive age"]
[{"$nulls":3},"Indiana",{"$nulls":14},"9C","Use program and epidemiologic data to identify which subgroups of MSM with primary and secondary syphilis and factors associated with transmission to target for partner services to yield high numbers of all partners treated in a timely fashion and for whom consequence of transmission is the greatest. As resources permit, provide timely partner services including comprehensive STD and HIV testing and linkage to care and needed prevention services to those subgroups of MSM with primary and secondary syphilis"]
[{"$nulls":3},"Iowa",{"$nulls":14},"10A","Identify all STD specialty clinics in the project area"]
[{"$nulls":3},"Kansas",{"$nulls":14},"10B","Promote quality STD care in those settings based on clinical guidelines and recommendations and promote strategies for expanding access to care in those settings"]
[{"$nulls":3},"Kentucky",{"$nulls":14},"11A","Assess GC treatment practices to identify and prioritize providers, organizations, and areas to target for promotion and improvement. Provide education and technical assistance to providers and organizations who prescribe non-recommended treatment for gonorrhea"]
[{"$nulls":3},"Los Angeles",{"$nulls":14},"11B","Assess syphilis treatment practices to identify and prioritize providers, organizations, and areas to target for promotion and improvement. Provide education and technical assistance to providers and organizations who prescribe non-recommended treatment for syphilis"]
[{"$nulls":3},"Louisiana",{"$nulls":14},"11C","Implement a Benzathine penicillin G forecasting inventory management system to monitor supply, and have a plan to address shortages in the applicant's project area. Assist providers and organizations who are unable to provide timely, recommended treatment for syphilis in getting access to medication or dispensing the treatment to the patient, as needed"]
[{"$nulls":3},"Maine",{"$nulls":14},"12A","For pregnant women: Assess screening and treatment practices to identify and prioritize providers, organizations, and areas to target for promotion and improvement. Provide education and technical assistance, for prenatal-care providers and organizations who do not regularly screen for syphilis as recommended"]
[{"$nulls":3},"Maryland",{"$nulls":14},"12B","For young adults and adolescents, particularly those seen in family planning clinics, adolescent health clinics, and primary care settings: Assess screening and treatment practices to identify and prioritize providers, organizations, and areas to target for promotion and improvement. Provide education and technical assistance to targeted providers and organizations to promote recommended screening and treatment"]
[{"$nulls":3},"Massachusetts",{"$nulls":14},"12C","For MSM, particularly those seen in lesbian, gay, bisexual, transgender and queer (LGBTQ) health centers, HRSA-funded HIV care settings, primary care settings, and clinics providing HIV PrEP: Assess screening and treatment practices to identify and prioritize providers, organizations, and areas to target for promotion and improvement. Provide education and technical assistance to targeted providers and organizations, to promote recommended screening and treatment"]
[{"$nulls":3},"Michigan",{"$nulls":14},"13A","Provide audience-appropriate, 508-compliant, STD-prevention information online, including answers to common STD questions (e.g., symptoms, testing methods, treatment) and places where testing and treatment are available"]
[{"$nulls":3},"Minnesota",{"$nulls":14},"14A","Notify local providers and organizations about important or timely STD-related issues, such as outbreaks, emerging diseases, recommended treatment changes, biomedical advances, and reporting requirements"]
[{"$nulls":3},"Mississippi",{"$nulls":14},"15A","Work with the CDC, the NNECS recipient, and other partners to identify STD-related policies of interest. Monitor proposed and actual changes in policies that may affect STD prevention programs"]
[{"$nulls":3},"Missouri",{"$nulls":14},"15B","Work with local policy liaisons and with partner organizations on the development of policies that enhance the work of the STD prevention program"]
[{"$nulls":3},"Montana",{"$nulls":14},"16A","Conduct regular analyses of trends in, geographic distribution of, and factors associated with reported cases using core epidemiologic variables"]
[{"$nulls":3},"Nebraska",{"$nulls":14},"16B","Disseminate, interpret, and discuss data and findings with internal and external stakeholders"]
[{"$nulls":3},"Nevada",{"$nulls":14},"16C","Assist local jurisdictions with analyzing their data on a regular basis, including analyses of trends, epidemiologic factors, and geographic distribution of cases, and help local areas identify outbreaks, gaps in services, or disparities in the burden of disease that should drive resource allocation"]
[{"$nulls":3},"New Hampshire",{"$nulls":14},"17A","Routinely analyze, synthesize and interpret surveillance, epidemiologic, program, and other data to strengthen the program's understanding of local STD epidemiology and program context. Evaluate progress, using scientific methods, program data, performance data, and cost data, and adjust program plans accordingly"]
[{"$nulls":3},"New Jersey",{"$nulls":14},"17B","Use findings from those analyses to identify the program's STD prevention and control priorities, populations, and geographic areas, to develop program plans, and to allocate staffing and other resources accordingly"]
[{"$nulls":3},"New Mexico"]
[{"$nulls":3},"New York"]
[{"$nulls":3},"New York City"]
[{"$nulls":3},"North Carolina"]
[{"$nulls":3},"North Dakota"]
[{"$nulls":3},"Ohio"]
[{"$nulls":3},"Oklahoma"]
[{"$nulls":3},"Oregon"]
[{"$nulls":3},"Pennsylvania"]
[{"$nulls":3},"Philadelphia"]
[{"$nulls":3},"Puerto Rico"]
[{"$nulls":3},"Rhode Island"]
[{"$nulls":3},"San Francisco"]
[{"$nulls":3},"South Carolina"]
[{"$nulls":3},"South Dakota"]
[{"$nulls":3},"Tennessee"]
[{"$nulls":3},"Texas"]
[{"$nulls":3},"US Virgin Islands"]
[{"$nulls":3},"Utah"]
[{"$nulls":3},"Vermont"]
[{"$nulls":3},"Virginia"]
[{"$nulls":3},"Washington"]
[{"$nulls":3},"West Virginia"]
[{"$nulls":3},"Wisconsin"]
[{"$nulls":3},"Wyoming"]

{"sheet":"Home Page","index":1,"n_rows":46,"n_cols":4,"rows_kept":46,"merged":[[1,3,1,4],[8,2,8,3],[16,1,16,4],[17,1,17,4],[18,1,18,4],[19,1,19,4],[22,1,22,4],[23,1,23,4],[24,1,24,4],[25,1,25,4],[27,1,27,4],[28,1,28,4],[29,1,29,4],[31,1,31,4],[45,1,45,4]]}
[]
[{"$nulls":3},"Form Approved \nOMB No. 0920-0879 \nExpiration Date 01/31/2021"]
[]
[null,{"$f":"Title1","v":"Strengthening STD Prevention and Control for Health Departments (STD PCHD)"}]
[]
[null,{"$f":"Title2","v":"5 Year Plan"}]
[null,{"$f":"Title3","v":"PCHD Years 1 - 5"}]
[]
[null,"Project Area:","[Choose your Project Area…]"]
[]
[null,"Period of Performance:",{"$f":"PeriodOfPerformance","v":"01/01/2019 - 12/31/2023"}]
[]
[null,"Submission Date:"]
[]
[null,null,"Go to PCHD 5 Year Plan >>"]
[null,"Instructions:"]
["\n\n","You may use this template to prepare a PCHD 5 Year Plan for DSTDP. Please refer to the supplemental guidance document for more information."]
["\n\n\n","Complete the tab titled \"PCHD 5 Year Plan\". You will be asked a series of questions that will allow you to reflect on how your STD program's context, goals, and objectives are related to the key strategies and activities put forth in this award."]
["\n\n","Applicants will only need to complete and submit the PCHD 5 Year Plan once during the five year period of performance of the award."]
["\n","If you need technical support at any time, please send an email with a detailed description of your need to the following address:"]
["\n","STD_PCHD@cdc.gov"]
[null,"Notes on Data Entry: "]
["\n\n\n","All light yellow cells are available for user input. You can type your responses directly into the yellow cells, or copy and paste your responses from another document into the cells. Press ALT+Enter to write on a new line in the same Excel cell."]
["\n\n","Boxes with a red corner have additional tips for data entry. Hover your cursor over them to view the tips. For optimal viewing, keep resolution to 100%."]
["\n\n","Drop-down menus are included in the PCHD 5 Year Plan, in the Program Priorities Section.  Click on the small arrow that appears in the cell to select drop-down values."]
["\n\n\n\n\n\n\n\n","Copying Information from Microsoft Word, PDF or Excel? \nStep 1:  Copy (Ctrl+C) the text you want to transfer and click in the yellow cell where you want to paste \n\nStep 2:  Click into the formula bar (fx) at the top of the screen, and paste (Ctrl+V)  -OR-  hit F2/double-click within the yellow cell to generate a flashing cursor, and then paste\n\n**If the light yellow cell is no longer yellow after you paste, or anything else goes wrong, hit Ctrl+Z to undo your action**"]
[null,"Saving and Submitting Your Work: "]
["\n\n\n\n\n","Click \"File\" from the ribbon above and then \"Save\" from the menu. If this is your first time saving this document, you will be prompted to choose a location for where this file will be saved. Please save this file as \"[ProjectAreaName]_5YearPlan_yy-mm-dd\" and as an .xlsm version. (Note: you will see a warning message reminding you that if you change the format of the document, you may lose some of the functionality. Click \"Ok\" and save the file in your preferred location.)"]
["\n\n\n\n\n","When you are finished with this document, there are two ways to package it for submission. Option 1 - click the button below, select a folder for where you would like the final file saved, and the file will be saved with an automatically-generated filename. You will no longer be able to edit any text, but you will be able to print out the work plan template."]
[null,"Option 2 - click \"File\" from the ribbon above and then \"Save As\" from the menu or use the button below. Choose the .xls or .xlsx file type from the \"Save as type\" drop-down menu. You will see a warning sign that says \"The following features cannot be saved in macro-free workbooks: VB project\". Click \"Yes\" to save the file as a .xls or .xlsx file type. You will still be able to edit light yellow cells, but a few features from this workbook will no longer be available."]
[]
[null,"To submit this document, attach the file ending in .xls or .xlsx to your application for this NOFO in Grants.gov."]
[]
[null,"Relevant Links:"]
[]
[null,"[insert link to NOFO award posting]"]
[null,"[insert link to NOFO technical notes]"]
[null,"[insert link to NOFO TA resources (PETT)]"]
[null,"[insert link to S.M.A.R.T. Objectives Builder]"]
[null,"[insert link to other guidance documents]"]
[null,"Microsoft Excel Basics"]
[]
[]
[]
[]
[null,"CDC estimates the average public reporting burden for this collection of information as 20 minutes per response, including the time for reviewing instructions, searching existing data/information sources, gathering and maintaining the data/information needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0879)."]

{"sheet":"PCHD 5 Year Plan","index":2,"n_rows":129,"n_cols":9,"rows_kept":129,"merged":[[2,1,2,4],[6,1,6,3],[7,1,7,4],[10,1,10,3],[11,1,11,4],[14,1,14,3],[15,1,15,4],[18,1,18,3],[19,1,19,4],[22,1,22,4],[33,1,33,3],[34,1,34,4],[37,1,37,3],[38,1,38,4],[41,1,41,3],[42,1,42,4],[45,1,45,4],[46,1,46,4],[49,1,49,4],[59,1,59,3],[60,1,60,4],[63,1,63,3],[64,1,64,4],[67,1,67,3],[68,1,68,4],[71,1,71,4],[72,1,72,4],[75,1,75,4],[84,1,84,3],[85,1,85,4],[88,1,88,3],[89,1,89,4],[92,1,92,3],[93,1,93,4],[96,1,96,3],[97,1,97,4],[100,1,100,4],[109,1,109,3],[110,1,110,4],[113,1,113,3],[114,1,114,4],[117,1,117,3],[118,1,118,4],[121,1,121,3],[122,1,122,4],[125,1,125,4]]}
[null,"<< Home Page",{"$nulls":4},"Line Spacing","Auto sizing for big fields","Identifier(s)>>"]
[null,{"$f":"\"PCHD \" & Title2","v":"PCHD 5 Year Plan"},{"$nulls":4},"20pt","this column width = 120 (B - E combined); must keep this condition true for proper auto sizing"]
[null,"This five year planning page is an opportunity for you to step back and reflect on how your STD program's context, goals, and objectives are related to the key strategies and activities put forth in this award. Applicants will only need to complete and submit the PCHD 5 Year Plan once during the five year period of performance of the award.",{"$nulls":4},"line\nline\nline",null,"Strategy Area ID"]
[" ","Surveillance",{"$nulls":6},1]
[]
[null,"Current Capability"]
[null,"What is the current capacity of your STD program, in this Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B8","v":0}]
[]
[null,"Strengths"]
[null,"What are the key strengths of your program in the STD Surveillance Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B12","v":0}]
[]
[null,"Limitations"]
[null,"What are the key limitations of program in the STD Surveillance Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B16","v":0}]
[]
[null,"Progress and Change"]
[null,"What major changes do you plan to make over the next 5 years in the STD Surveillance Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B20","v":0}]
[]
[null,"Program Priorities"]
[null,"Use the space below to rate the importance of the primary strategies to your STD Surveillance program, and your program's level of strength in implementing them.",{"$nulls":4},"line\nline"]
[null,"Surveillance Primary Strategy","Importance: Among Surveillance strategies, how would you rate the relative importance of this strategy to your STD program, based on your resources, morbidity, and local priorities?","Implementation: How strong or weak would you say your STD program is in implementing the following strategies?","Comments (Optional): If needed, use the space below to provide additional information on the strategy importance or implementation."]
[null,"Conduct Chlamydia (CT) surveillance"]
[null,"Conduct Gonorrhea (GC) surveillance"]
[null,"Conduct syphilis surveillance"]
[null,"Conduct congenital syphilis (CS) surveillance"]
[null,"Conduct surveillance of adverse outcomes of STDs"]
[]
[" ","Disease Investigation and Intervention ",null,null,"Back to Top ^",{"$nulls":3},2]
[]
[null,"Current Capability"]
[null,"What is the current capacity of your STD program, in this Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B35","v":0}]
[]
[null,"Strengths"]
[null,"What are the key strengths of your program in the STD Disease Investigation and Intervention Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B39","v":0}]
[]
[null,"Limitations"]
[null,"What are the key limitations of your program in the STD Disease Investigation and Intervention Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B43","v":0}]
[]
[null,"Progress and Change"]
[null,"What major changes do you plan to make over the next 5 years in the STD Disease Investigation and Intervention Strategy Area?",{"$nulls":4},"line\nline"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B47","v":0}]
[]
[null,"Program Priorities"]
[null,"Use the space below to rate the importance of the primary strategies to your STD Disease Investigation and Intervention program, and your program's level of strength in implementing them.",{"$nulls":4},"line\nline"]
[null,"Disease Investigation and Intervention Primary Strategy","Importance: Among Disease Investigation and Intervention strategies, how would you rate the relative importance of this strategy to your STD program, based on your resources, morbidity, and local priorities?","Implementation: How strong or weak would you say your STD program is in implementing the following strategies?","Comments (Optional): If needed, use the space below to provide additional information on the strategy importance or implementation."]
[null,"Respond to STD-related outbreaks"]
[null,"Conduct health department disease investigation for pregnant women and other reproductive-age women with syphilis"]
[null,"Promote Expedited Partner Therapy (EPT) (where permissible) to partners of chlamydia and/or gonorrhea cases"]
[null,"Conduct health department syphilis disease investigation and intervention for men with syphilis"]
[]
[" ","Screening, Diagnosis, and Treatment",null,null,"Back to Top ^",{"$nulls":3},3]
[]
[null,"Current Capability"]
[null,"What is the current capacity of your STD program, in this Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B61","v":0}]
[]
[null,"Strengths"]
[null,"What are the key strengths of your program in the STD Screening, Diagnosis, and Treatment Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B65","v":0}]
[]
[null,"Limitations"]
[null,"What are the key limitations of your program in the STD Screening, Diagnosis, and Treatment Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B69","v":0}]
[]
[null,"Progress and Change"]
[null,"What major changes do you plan to make over the next 5 years in the STD Screening, Diagnosis, and Treatment Strategy Area?",{"$nulls":4},"line\nline"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B73","v":0}]
[]
[null,"Program Priorities"]
[null,"Use the space below to rate the importance of the primary strategies to your STD Screening, Diagnosis, and Treatment program, and your program's level of strength in implementing them.",{"$nulls":4},"line\nline"]
[null,"Screening, Diagnosis, and Treatment Primary Strategy","Importance: Among Screening, Diagnosis, and Treatment strategies, how would you rate the relative importance of this strategy to your STD program, based on your resources, morbidity, and local priorities?","Implementation: How strong or weak would you say your STD program is in implementing the following strategies?","Comments (Optional): If needed, use the space below to provide additional information on the strategy importance or implementation."]
[null,"Promote quality STD specialty care services"]
[null,"Promote CDC-recommended treatment for gonorrhea and syphilis"]
[null,"Promote CDC-recommended screening for, and treatment of, STDs among priority populations"]
[]
[" ","Prevention and Policy",null,null,"Back to Top ^",{"$nulls":3},4]
[]
[null,"Current Capability"]
[null,"What is the current capacity of your STD program, in this Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B86","v":0}]
[]
[null,"Strengths"]
[null,"What are the key strengths of your program in the STD Prevention and Policy Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B90","v":0}]
[]
[null,"Limitations"]
[null,"What are the key limitations of your program in the STD Prevention and Policy Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B94","v":0}]
[]
[null,"Progress and Change"]
[null,"What major changes do you plan to make over the next 5 years in the STD Prevention and Policy Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B98","v":0}]
[]
[null,"Program Priorities"]
[null,"Use the space below to rate the importance of the primary strategies to your STD Prevention and Policy program, and your program's level of strength in implementing them.",{"$nulls":4},"line\nline"]
[null,"Prevention and Policy Primary Strategy","Importance: Among Prevention and Policy strategies, how would you rate the relative importance of this strategy to your STD program, based on your resources, morbidity, and local priorities?","Implementation: How strong or weak would you say your STD program is in implementing the following strategies?","Comments (Optional): If needed, use the space below to provide additional information on the strategy importance or implementation."]
[null,"Promote STD prevention to the public"]
[null,"Promote STD prevention and reporting to provider community"]
[null,"Monitor STD-related policies and policy development"]
[]
[" ","Data Use and Utilization",null,null,"Back to Top ^",{"$nulls":3},5]
[]
[null,"Current Capability"]
[null,"What is the current capacity of your STD program, in this Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B111","v":0}]
[]
[null,"Strengths"]
[null,"What are the key strengths of your program in the STD Data Use and Utilization Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B115","v":0}]
[]
[null,"Limitations"]
[null,"What are the key limitations of your program in the STD Data Use and Utilization Strategy Area?"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B119","v":0}]
[]
[null,"Progress and Change"]
[null,"What major changes do you plan to make over the next 5 years in the STD Data Use and Utilization Strategy Area?",{"$nulls":4},"line\nline"]
[{"$nulls":6},"line\nline\nline\nline",{"$f":"B123","v":0}]
[]
[null,"Program Priorities"]
[null,"Use the space below to rate the importance of the primary strategies to your STD Data Use and Utilization program, and your program's level of strength in implementing them.",{"$nulls":4},"line\nline"]
[null,"Data Use and Utilization Primary Strategy","Importance: Among Data Use and Utilization strategies, how would you rate the relative importance of this strategy to your STD program, based on your resources, morbidity, and local priorities?","Implementation: How strong or weak would you say your STD program is in implementing the following strategies?","Comments (Optional): If needed, use the space below to provide additional information on the strategy importance or implementation."]
[null,"Conduct epidemiologic analysis, translation and dissemination"]
[null,"Conduct data-driven planning, analysis, monitoring and evaluation for program improvement"]